Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 33 out of 100. Risk factors

Topic: Amyloid, tau and blood-test diagnosis

Plain-language summary

Among 15,346 White, 829 Latino, 637 Black/African American, and 321 Asian individuals, 51% were female, mean age was 75.7 years, 535 (3.8%) resided in ADI 91 to 100 decile, and 61.6% were amyloid PET positive. The ADI 91-100 decile was associated with lower odds of PET positivity by visual interpretation (odds ratio [OR] 0.80, 95% confidence interval [CI] 0.67-0.96, p ≤ .001) but not PET Centiloid value ≥ 40 versus ≤ 10 (OR 0.81, 95% CI 0.66-1.01, p = 0.060). Residence in the most disadvantaged neighborhoods may be associated with lower amyloid pathology in cognitively impaired individuals.

What this study adds

Evidence grade: Low

People with cognitive impairment living in the most disadvantaged neighborhoods were less likely to have a positive amyloid PET scan by visual reading, though the result was not significant using a different amyloid measure. Reported effect size: 3.8%; 61.6%; OR 0.81.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Windon, C., Whitmer, R. A., Hillner, B. E., Steingrimsson, J., Blazhenets, G., Gatsonis, C., et al. (2026). Association of residential neighborhood disadvantage with amyloid PET positivity among cognitively impaired individuals. Carolina Digital Repository (University of North Carolina at Chapel Hill). https://doi.org/10.17615/0g36-z486

Vancouver

Windon C, Whitmer RA, Hillner BE, Steingrimsson J, Blazhenets G, Gatsonis C, et al. Association of residential neighborhood disadvantage with amyloid PET positivity among cognitively impaired individuals. Carolina Digital Repository (University of North Carolina at Chapel Hill). 2026. doi:10.17615/0g36-z486.

BibTeX

@article{windon2026-4e49a7d2,
  author  = {Windon, Charles and Whitmer, Rachel A and Hillner, Bruce E. and Steingrimsson, Jon and Blazhenets, Ganna and Gatsonis, Constantine and Possin, Katherine L. and Miller, Bruce L. and others},
  title   = {{Association of residential neighborhood disadvantage with amyloid PET positivity among cognitively impaired individuals}},
  journal = {Carolina Digital Repository (University of North Carolina at Chapel Hill)},
  year    = {2026},
  doi     = {10.17615/0g36-z486},
  url     = {https://doi.org/10.17615/0g36-z486}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

Key findings

Why it matters

People with cognitive impairment living in the most disadvantaged neighborhoods were less likely to have a positive amyloid PET scan by visual reading, though the result was not significant using a different amyloid measure. This suggests neighborhood disadvantage may be linked to lower amyloid pathology in this group.

Study details

How this study scored 33/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record left out, no data; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 5 of 5; Sample size 0 of 4; Effect reported 3 of 3; Studied in people 0 of 3; Randomized / blinded 0 of 2; Times cited 0 of 7; Citations per year 0 of 5; Impact for its field and year 0 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 1 of 4; Institution's track record 2 of 3; Multicenter collaboration 0 of 3; Indexed in PubMed 1 of 2; Free to read 2 of 2. 32 of the 96 points it could be judged on, which is 33 of 100. Total 33 of 100.32 of the 96 points we could judge = 33 of 100

Published in a peer-reviewed journal. Scored zero for study design, sample size, studied in people and randomized / blinded because the record does not state it. We have no data on journal's citation record, so that was left out: it earned 32 of the 96 points we could judge it on, which is 33 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Carolina Digital Repository (University of North Carolina at Chapel Hill))
Journal's citation record — / 4 No journal record from OpenAlex — left out of this score
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 3 / 3 Effect reported with a statistic (interval, p-value, ratio or similar)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 0 / 7 Cited 0 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.0 citations a year over 2 year(s) since 2026
Impact for its field and year 0 / 6 Cited 0.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 1 / 4 Last-listed author Justin Romanoff: h-index 15 (OpenAlex, whole career)
Institution's track record 2 / 3 University of North Carolina at Chapel Hill: institution h-index 1,674 (OpenAlex)
Multicenter collaboration 0 / 3 OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 2 / 2 Free to read
Points 32 / 96 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 32 of the 96 points we could judge it on is 33 out of 100.
Total 33 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Related studies in Risk factors from nearby years

Also tagged “precursor”

1,337 studies in the library carry the topic tag “precursor”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,337 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Risk factors

See all studies in Risk factors →